Skip to main content

Companies researching REVLIMID (lenalidomide)

Lenalidomide, marketed as REVLIMID, is a drug used to treat conditions such as myelodysplastic syndrome, multiple myeloma, and mantle cell lymphoma.

List of companies that research REVLIMID (lenalidomide)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies

United States

Pharmaceutical Manufacturing

39k

$46B

REVLIMID (lenalidomide)

United States

Hospitals and Health Care

13k

$2.4B

REVLIMID (lenalidomide)

Canada

Hospitals and Health Care

5k

REVLIMID (lenalidomide)

United States

Pharmaceutical Manufacturing

915

REVLIMID (lenalidomide)

United States

Hospitals and Health Care

80k

$284B

REVLIMID (lenalidomide)

Czech Republic

Pharmaceutical Manufacturing

4.7k

$528M

REVLIMID (lenalidomide)

Showing top companies out of 15 that research REVLIMID (lenalidomide). Get the full list on TheirStack.

Frequently asked questions